LEVIN JEREMY M bought OVID

December 11, 2025 · Form 4 insider transaction

LEVIN JEREMY M bought 71 shares of Ovid Therapeutics Inc., a transaction worth N/A. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 7 days after the transaction.

Direction
Acquired (buy-side)
Shares
71
Price
N/A
Total value
N/A
RoleOfficer, Director
SecuritySeries B Convertible Preferred Stock
Transaction codeP: Open-market purchase
Transaction dateDecember 11, 2025
Filing dateDecember 18, 2025
Shares owned after71
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Each share of Series B Convertible Preferred Stock automatically converted into 1,000 shares Common Stock at 5 p.m. Eastern Time on December 15, 2025, pursuant to the approval of the Issuer's Stockholders on December 11, 2025.; The reported securities are included within 71 investment units purchased by the Reporting Person for $1,400 per investment unit. Each investment unit consists of one share of Series B Convertible Preferred Stock, one Series A Warrant to purchase 666.66 shares of common stock, and one Series B Warrant to purchase 500 shares of common stock.

View the original Form 4 on SEC EDGAR